Industrial research of new DNA technologies for medical diagnosis: next generation sequencing and miRNA (Q10109)

From EU Knowledge Graph
Revision as of 14:58, 22 October 2020 by DG Regio (talk | contribs) (‎Removed claim: summary (P836): The project focuses on research in a new area of DNA technology with a high potential for future use in clinical practice to improve the diagnosis of civilisation diseases. The aim of the project is research from clinically meaningful Mirna molecules and their detection and preparation of two prototypes of new generation sequencing kits intended for the diagnosis of cystic fibrosis and breast and ovarian cancer. The output of the project will...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Industrial research of new DNA technologies for medical diagnosis: next generation sequencing and miRNA
Project in Czech Republic financed by DG Regio

    Statements

    country
    Czechia
    0 references
    EU contribution
    10,847,356.92 Czech koruna
    0 references
    433,894.28 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    18,868,250.0 Czech koruna
    0 references
    754,730.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    57.49 percent
    0 references
    start time
    1 January 2016
    0 references
    expected end time
    28 September 2019
    0 references
    beneficiary name (string)
    ELISABETH  PHARMACON, spol. s r.o.
    0 references
    coordinate location

    49°11'55.75"N, 16°38'29.22"E
    0 references
    postal code
    61500
    0 references
    summary
    Projekt se zaměřuje na výzkum v nové oblasti DNA technologií s velkým potenciálem budoucího využití v klinické praxi pro zlepšení diagnostiky civilizačních chorob. Cílem projektu je výzkum klinicky významných miRNA molekul a jejich detekce a příprava dvou prototypů souprav pro sekvenování nové generace určených pro diagnostiku cystické fibrózy a rakoviny prsu a vaječníků. Výstupem projektu budou dva prototypy, na které bude možné navázat vývoj komerčních diagnostických souprav. a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/15_018/0004701
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q10109&oldid=6595103"